Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Net Cash Flow (2016 - 2025)

Surgery Partners' Net Cash Flow history spans 12 years, with the latest figure at $36.5 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 23.48% year-over-year to $36.5 million; the TTM value through Dec 2025 reached -$29.6 million, down 140.22%, while the annual FY2025 figure was -$29.6 million, 140.22% down from the prior year.
  • Net Cash Flow for Q4 2025 was $36.5 million at Surgery Partners, up from -$46.7 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $223.7 million in Q1 2021 and bottomed at -$151.5 million in Q2 2022.
  • The 5-year median for Net Cash Flow is -$10.8 million (2022), against an average of -$3.9 million.
  • The largest annual shift saw Net Cash Flow surged 218.95% in 2024 before it plummeted 662.65% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at $59.5 million in 2021, then surged by 115.29% to $128.1 million in 2022, then crashed by 131.3% to -$40.1 million in 2023, then soared by 218.95% to $47.7 million in 2024, then dropped by 23.48% to $36.5 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Net Cash Flow are $36.5 million (Q4 2025), -$46.7 million (Q3 2025), and $20.8 million (Q2 2025).